Inventory of the Recommendations for Patients with Pollen Allergies and Evaluation of Their Scientific Relevance.


Journal

International archives of allergy and immunology
ISSN: 1423-0097
Titre abrégé: Int Arch Allergy Immunol
Pays: Switzerland
ID NLM: 9211652

Informations de publication

Date de publication:
2020
Historique:
received: 13 05 2020
accepted: 20 07 2020
pubmed: 11 9 2020
medline: 27 1 2021
entrez: 10 9 2020
Statut: ppublish

Résumé

Pollens are responsible for allergic rhinitis, conjunctivitis, and asthma. The incidence of these diseases, which have adversely impacted the social and professional lives of people who are allergic to pollen, has tripled in the past 25 years. Official institutes, health care institutions, public interest groups, and mainstream news media provide people who are allergic to pollen with advice aimed at reducing their symptoms. The aim of this work was to provide an inventory of the prevention guidelines in the world and to evaluate their scientific relevance. A PubMed search was carried out using specific keywords. The scientific relevance of the recommendations was evaluated based on the publications disproving or confirming their merit. The guidelines issued by 12 countries in Europe, North America, and Australia were inventoried. The recommendations for avoidance were most often based on scientific data regarding their impact on pollen exposures, but they have not been clinically validated. Several studies provided additional details, however, that allowed the guidelines to be further substantiated. These guidelines have been adopted in numerous industrialized countries in the world, and they generally appear to be of relevance.

Identifiants

pubmed: 32911472
pii: 000510313
doi: 10.1159/000510313
doi:

Substances chimiques

Allergens 0
Antigens, Plant 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

839-852

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Solenne Roubelat (S)

Aix-Marseille University and the French Clean Air Association, Marseille, France.

Jean-Pierre Besancenot (JP)

French National Aerobiological Network, Brussieu, France.

Daniel Bley (D)

UMR 7300 ESPACE, Arbois Mediterranean Europole, Aix-en-Provence, France.

Michel Thibaudon (M)

French National Aerobiological Network, Brussieu, France.

Denis Charpin (D)

Aix-Marseille University and the French Clean Air Association, Marseille, France, charpindenis27@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH